Synonyms: Apretude® | CAB | Cabenuva® (cabotegravir + rilpivirine) | GSK-1265744 | GSK1265744 | GSK744 | Vocabria®
cabotegravir is an approved drug (EMA (2020), FDA (2021))
Compound class:
Synthetic organic
Comment: Cabotegravir (GSK1265744, CAB) is a long-acting HIV integrase inhibitor. It is structurally related to dolutegravir.
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (EMA (2020), FDA (2021)) |
International Nonproprietary Names | |
INN number | INN |
9903 | cabotegravir |
Synonyms |
Apretude® | CAB | Cabenuva® (cabotegravir + rilpivirine) | GSK-1265744 | GSK1265744 | GSK744 | Vocabria® |
Database Links | |
BindingDB Ligand | 50492496 |
CAS Registry No. | 1051375-10-0 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL2403238 |
DrugBank Ligand | DB11751 |
GtoPdb PubChem SID | 440816755 |
PubChem CID | 54713659 |
Search Google for chemical match using the InChIKey | WCWSTNLSLKSJPK-LKFCYVNXSA-N |
Search Google for chemicals with the same backbone | WCWSTNLSLKSJPK |
Search PubMed clinical trials | cabotegravir |
Search PubMed titles | cabotegravir |
Search PubMed titles/abstracts | cabotegravir |
UniChem Compound Search for chemical match using the InChIKey | WCWSTNLSLKSJPK-LKFCYVNXSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | WCWSTNLSLKSJPK-LKFCYVNXSA-N |